Methazolamide

From Wikipedia, the free encyclopedia
Methazolamide
Systematic (IUPAC) name
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a601233
Pregnancy cat. C (US)
Legal status -only (US)
Routes Oral
Pharmacokinetic data
Protein binding 55%
Half-life 14 hours
Identifiers
CAS number 554-57-4 YesY
ATC code S01EC05
PubChem CID 4100
DrugBank DB00703
ChemSpider 3958 YesY
UNII W733B0S9SD YesY
KEGG D00655 N
ChEMBL CHEMBL19 N
Synonyms N-(3-Methyl-5-sulfamoyl-3H-1,3,4-thiadiazol-2-ylidene) ethanamide
Chemical data
Formula C5H8N4O3S2 
Mol. mass 236.274 g/mol
 N (what is this?)  (verify)

Methazolamide (Neptazane) is a carbonic anhydrase inhibitor.

References

  • Iyer G, Bellantone R, Taft D (1999). "In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics.". J Pharmacokinet Biopharm 27 (1): 4566. doi:10.1023/A:1020630712388. PMID 10533697. 
  • RxList. "Neptazane". Retrieved August 20, 2006. 
  • Shirato S, Kagaya F, Suzuki Y, Joukou S (1997). "Stevens–Johnson syndrome induced by methazolamide treatment.". Arch Ophthalmol 115 (4): 5503. PMID 9109770. 
  • Skorobohach B, Ward D, Hendrix D (2003). "Effects of oral administration of methazolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.". Am J Vet Res 64 (2): 1837. doi:10.2460/ajvr.2003.64.183. PMID 12602587. 


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.